Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BMS-741672 in drug-naive type 2 diabetes
NCT00699790Phase 2Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Feb 2009
- Primary completion
- Dec 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BMS-741672 in type 2 diabetes mellitus (T2DM), sponsored by Bristol Myers Squibb. Started Feb 2009; status: completed.
02
Drugs
BMS-741672
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00699790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00699790.